Introduction
============

Extended-spectrum β-lactamases (ESBLs) have increased dramatically among clinical *Enterobacteriaceae* isolates during last three decades. In the last two decades, CTX-M replaces SHV as the major type of ESBLs disseminating worldwide ([@B38]; [@B8]). Surveillance in Asia, Latin America, and European revealed dramatically increasing resistance to cephalosporins amongst *Escherichia coli* and *Klebsiella* spp., largely contingent on the spread of CTX-M ESBLs ([@B19]; [@B38]). In most of the Europe countries, CTX-M-15 is the most prevalent ESBL type ([@B27]), and recently also disseminated in America, Canada, and Latin America ([@B12]; [@B33]; [@B18]). In China, *bla*~CTX-M-14~ is identified as the most prevalent ESBL gene ([@B2]; [@B35]).

It has been suggested that the frequent acquirement of plasmids harboring *bla*~CTX-M~ is largely responsible for the increase of CTX-M-producing *Enterobacteriaceae*. The *bla*~CTX-M~ genes are found to associate with certain replicon types of plasmids, mainly including IncF, IncI, IncN, IncHI2, IncL/M, and IncK groups ([@B38]). The IncF group (FIA, FIB, and FII) is believed to play an important role in the dissemination of *bla*~CTX-M-15~ gene, and IncF, IncK and IncI1 largely contribute to the dissemination of *bla*~CTX-M-14~ gene. The *bla*~CTX-M-3~ gene is mainly harbored by plasmids of IncL/M and IncI1, and *bla*~CTX-M-9~ gene by IncHI2 plasmids ([@B38]). Multiple mobile genetic elements, e.g., IS*Ecp1* and IS*CR1*, are involved in the mobilization of *bla*~CTX-M~ genes as well ([@B29]; [@B38]).

Extended-spectrum β-lactamase-producing *K. pneumoniae* (ESBL-Kp) has recently become an important nosocomial pathogen ([@B3]; [@B24]; [@B27]; [@B22]). In the tertiary hospitals of China, approximate 50% nosocomial-acquired infections are caused by ESBL-Kp and *bla*~CTX-M-15~ and *bla*~CTX-M-14~ are the predominant genotypes ([@B34]; [@B20]; [@B35]). Recently, the prevalence rate of ESBL-Kp in community-acquired infections is increasing even causing invasive infection ([@B17]; [@B31]). However, limited knowledge about the dissemination of community-onset ESBL-Kp on national scale in China, especially in settings of secondary hospitals or primary health care. This study was to investigate the epidemiological and genetic characteristics of ESBL-Kp isolates causing community-onset infections in 31 secondary hospitals across China.

Materials and Methods {#s1}
=====================

Collection of Clinical Isolates
-------------------------------

Isolates were collected from August 2010 to 2011 in 31 secondary hospitals locating in 11 provinces representing seven major geographic regions of China (listed in **Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). Patients were selected for this study using the criteria as previous described ([@B37]). Bacterial strains were isolated from clinical specimens (urine, blood, sputum, abscesses, and secretions) and identified using API20 (bioMérieux, Durham, NC, USA). All the pure cultures were frozen at -80°C and shipped to our laboratory for re-identification and further analysis as described previously ([@B37]).

Antimicrobial Susceptibility Testing
------------------------------------

Minimum inhibitory concentrations (MICs) of 18 antimicrobial agents (ampicillin, piperacillin, cefazolin, cefuroxime, ceftazidime, ceftriaxone, cefepime, ampicillin-sulbactam, piperacillin-tazobactam, cefoperazone/sulbactam, cefoxitin, biapenem, imipenem, meropenem, amikacin, gentamicin, ciprofloxacin, levofloxacin, and fosfomycin) were determined by agar dilution method according to Clinical and Laboratory Standards Institute ([@B9]). The breakpoint of biapenem was interpreted according to the recommended point of imipenem by CLSI ([@B9]). The breakpoint interpretation of cefoperazone/sulbactam referred to that of cefoperazone and sulbactam. ESBL phenotype was confirmed by the standard double disc synergy test (DDST) with cefotaxime (30 ug) and ceftazidime (30 ug) alone and in combination with clavulanic acid (10 ug; Oxoid Limited, UK) as recommended by CLSI. *E. coli* ATCC 25922 and *K. pneumoniae* ATCC 700603 were used as quality control.

Detection of Genes Encoding β-Lactamase and *K. pneumoniae*-Carbapenemase (KPC)
-------------------------------------------------------------------------------

PCR amplification was used to detect β-lactamase genes (*bla*~CTX-M~, *bla*~SHV~, *bla*~TEM~, *bla*~OXA-1~ group, *bla*~OXA-10~ group, *bla*~V\ EB~, *bla*~PER~, *bla*~GES~, *bla*~CMY\ -1~ group, *bla*~CMY\ -2~ group, and *bla*~DHA~) and KPC gene (*bla*~KPC~). Primers used for PCR detection and sequencing were acquired from a previous study ([@B37]). Sequencing results were analyzed online using Basic Local Alignment Search Tool (BLAST), and were further refined with use of a β-lactamase database^[1](#fn01){ref-type="fn"}^.

Multi-Locus Sequence Typing (MLST)
----------------------------------

Multi-Locus Sequence Typing was performed on 127 ESBL-Kp (69 *bla*~CTX-M-14~, 58 *bla*~CTX-M-15~) using the scheme of Institute Pasteur as described previously ([@B13]). New alleles and STs were assigned by the MLST database^[2](#fn02){ref-type="fn"}^. Clonal analysis of MLST data was performed using eBURST v3 ([@B14]). Clonal complexes (CCs) were defined as groups of two or more independent isolates that shared identical alleles at six loci. Each complex was named after the putative founder ST. A minimal spanning tree (MST) was generated by using BioNumerics v7.0 (Applied Maths, Sint-Martens-Latem, Belgium) to provide a graphical representation of the clonal distribution of ESBL-Kp. Neighbor-joining trees were constructed from concatenated sequences of seven MLST loci using the MEGA6 program with Kimura's two-parameter model ([@B30]).

Whole-Genome Sequencing (WGS) and Data Analysis
-----------------------------------------------

Eleven ESBL-Kp were selected to WGS for further analysis of genetic environment of ESBL genes and plasmid characteristics, including one CTX-M-3-producing isolate, two CTX-M-9-producing isolates, seven CTX-M-14-producing isolates, and one CTX-M-15-producing isolate. Genomic DNA was extracted using QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) and sequenced via HiSeq 2000 (Illumina, San Diego, CA, USA) with a 2 × 125 bp paired-end strategy. *De novo* assembly was generated by using the CLC Genomics Workbench, version 8.0.3 (CLC bio, Aarhus, Denmark). The plasmid analysis was performed as described previously ([@B39]). In brief, the plasmids backbones were derived dependent on BLASTn. The contigs of each sample were blasted against the reference plasmid and plotted by BLAST Ring Image Generator (BRIG) ([@B1]).

Accession Numbers
-----------------

All sequence data of six novel SHV variants are assigned in the GenBank database under the following accession numbers: KC688280, KC688281, KC688282, KC688283, KC688284, and KC688285.

This Whole Genome Shotgun project has been deposited at GenBank under the accession LYWN00000000, LYWO00000000, LYWP00000000, LYWQ00000000, LYWR00000000, LYWS00000000, LYWT00000000, LYWU00000000, LYWV00000000, LYWW00000000, LYWX00000000. The version described in this paper is version XXXX01000000.

Results
=======

Specimen Types and Patient Demographics
---------------------------------------

A total of 578 *K. pneumoniae* isolates were collected and identified from sputum (73.9%), urine (11.2%), blood (5.5%), abscess (3.3%), throat swab (2.4%), and unknown specimen (3.6%). In total, 61.2% of isolates were obtained from males. The distribution of patients' age groups was as follows: ≤1 years, 20.2%; 2--17 years, 5.6%; 18--45 years, 20.2%; 46--64 years, 22.2%; and ≥65 years, 31.7%.

Prevalence of ESBL-Kp Largely Varied across the Surveyed Regions
----------------------------------------------------------------

The results of antimicrobial susceptibility tests are summarized in **Table [1](#T1){ref-type="table"}**. All isolates were susceptible to biapenem, and only one isolate was resistant to imipenem and meropenem. Additionally, 92.4, 91.5, and 91.4% of isolates were susceptible to amikacin, cefoperazone-sulbactam and fosfomycin, respectively. Notably, 184 *K. pneumoniae* isolates (31.9%) showed ESBL phenotype with resistance to cefuroxime (97.9%), cefazolin (97.3%), ceftriaxone (96.8%), piperacillin (96.8%), gentamicin (68.1%), and ampicillin-sulbactam (67.9%). The prevalence of ESBL-Kp varied from 10.2 to 50.3% across different regions (**Table [2](#T2){ref-type="table"}**).

###### 

Results for susceptibility tests and Minimum inhibitory concentrations (MICs) for *K. pneumoniae* strains (*n* = 587) isolated from 31 county hospitals.

                            All isolates (*n* = 578)   ESBL-positive (phenotype) isolates (*n* = 184)                                                               
  ------------------------- -------------------------- ------------------------------------------------ ------- ------- ------------- ------ ------ ------- ------- -------------
  Ampicillin                86.3                       2.3                                              64      \>256   0.5--1024     99     0.5    \>256   \>256   1--1024
  Piperacillin              38.1                       56.7                                             8       \>256   0.03--1024    96.8   0      \>256   \>256   32--1024
  Ampicillin-sulbactam      26.1                       60.9                                             8       64      0.03--1024    67.9   10     32      128     0.125--1024
  Cefoperazone-sulbactam    2.5                        91.5                                             1       16      0.03--512     7.3    74.3   8       32      0.125--512
  Piperacillin-tazobactam   1.3                        88.2                                             4       32      0.015--1024   3.7    70     16      32      2--1024
  Cefazolin                 39.4                       59.9                                             2       256     0.5--256      97.3   2.7    256     256     0.5--256
  Cefuroxime                37                         59.9                                             4       256     0.125--256    97.9   1.1    256     256     4--256
  Ceftazidime               14.7                       81.2                                             0.25    32      0.015--256    44     45     8       128     0.015--256
  Ceftriaxone               31.2                       68.1                                             0.125   64      0.03--512     96.8   1.6    32      128     1--512
  Cefepime                  11.5                       83.3                                             0.5     32      0.03--1024    33.5   51.3   8       128     0.03--1024
  Cefoxitin                 10.2                       86.4                                             4       32      0.25--512     30.4   65.4   4       128     1--512
  Biapenem                  0                          100                                              0.064   0.125   0.015--1      0      100    0.064   0.125   0.015--1
  Imipenem                  0.2                        99.8                                             0.25    0.25    0.015--16     0.5    99.5   0.25    0.25    0.015--16
  Meropenem                 0.2                        99.8                                             0.032   0.125   0.015--16     0.5    99.5   0.016   0.125   0.015--16
  Amikacin                  7.6                        92.4                                             2       8       0.03--512     20.5   79.5   2       128     0.06--512
  Gentamicin                30.1                       68.6                                             1       128     0.125--512    68.1   30.9   64      128     0.25--512
  Ciprofloxacin             15                         80.6                                             0.125   16      0.015--256    31.4   57.1   1       64      0.015--256
  Levofloxacin              11.6                       86.5                                             0.125   8       0.006--256    23.7   71.6   1       16      .015--256
  Fosfomycin                4.7                        91.4                                             16      64      0.25--256     8.1    85.9   16      128     0.5--256
                                                                                                                                                                    

###### 

Geographical distribution of ESBL-producing *K. pneumoniae* isolates in seven regions of China.

  ESBL genotype                   No. of isolates (prevalence, %)                                                                               
  ------------------------------- --------------------------------- ------------ ------------ ----------- ------------ ----------- ------------ -------------
  CTX-M-1 group                   8                                 33           12           1           10           2           10           76
      CTX-M-15                    2                                 22           9            1           1            1           4            40
      CTX-M-55                    3                                 1                                     2            1           1            8
      CTX-M-3                     3                                 9            3                        7                        5            27
      CTX-M-101                                                     1                                                                           1
  CTX-M-9 group                   6                                 25           6            4           5            4           6            56
      CTX-M-14                    6                                 23           5            4           5            4           5            52
      CTX-M-9                                                       2                                                                           2
      CTX-M-27                                                                                                                     1            1
      CTX-M-65                                                                   1                                                              1
  SHV-type                        5                                 5            1                        3            1           2            17
      SHV-27                      3                                 2                                     3                        1            9
      SHV-2                                                         2                                                              1            3
      SHV-12                      2                                 1            1                                                              4
      SHV-41                                                                                                           1                        1
  CTX-M-1+9 groups                                                  15           3                                     2           1            21
      CTX-M-14 +CTX-M-3                                             6            1                                     2                        9
      CTX-M-14+ CTX-M-15                                            6            2                                                              8
      CTX-M-15+ CTX-M-24                                                                                                           1            1
      CTX-M-15+ CTX-M-9                                             3                                                                           3
  CTX-M+SHV                       3                                 9            1                        1                                     14
      CTX-M-3+SHV-2               2                                              1                                                              3
      CTX-M-3+SHV-12              1                                                                                                             1
      CTX-M-15+SHV-12                                                                                     1                                     1
      CTX-M-14+SHV-2                                                1                                                                           1
      CTX-M-14+SHV-27                                               1                                                                           1
      CTX-M-15+SHV-27                                               1                                                                           1
      CTX-M-14+CTX-M-15+ SHV-27                                     2                                                                           2
      CTX-M-14+CTX-M-15+ SHV-38                                     1                                                                           1
      CTX-M-15+CTX-M-9+ SHV-27                                      3                                                                           3
                                                                                                                                                
  Total                           22 (31.0%)                        86 (50.3%)   23 (31.9%)   5 (10.2%)   20 (38.5%)   9 (45.0%)   19 (13.3%)   184 (31.8%)
                                                                                                                                                

CTX-M-14 and CTX-M-15 Were the Predominant ESBL Genotypes
---------------------------------------------------------

The *bla*~CTX-M~ genes were detected in 90.8% (*n* = 167) of the 184 ESBL-Kp isolates. CTX-M-1 group and CTX-M-9 group genes were identified in 109 and 85 isolates, respectively, and both gene groups co-existed in 27 isolates (**Table [2](#T2){ref-type="table"}**). The *bla*~CTX-M-14~ gene was the most prevalent one (*n* = 74), followed by *bla*~CTX-M-15~ (*n* = 60), *bla*~CTX-M-3~ (*n* = 40), *bla*~CTX-M-55~ (*n* = 8), *bla*~CTX-M-9~ (*n* = 8), and *bla*~CTX-M-27~, *bla*~CTX-M-24~, *bla*~CTX-M-65~, and *bla*~CTX-M-101~ (*n* = 1 for each).

Various SHV genes were detected in 31 ESBL isolates (19.1%), including SHV-27 (*n* = 16), SHV-2 (*n* = 7), SHV-12 (*n* = 6), SHV-41 (*n* = 1), and SHV-38 (*n* = 1). Additionally, nine isolates carried an inhibitor-resistant SHV variant SHV-26. The concomitance of SHV and CTX-M genes was identified in 14 isolates. VEB-1 was detected in one isolate, co-existed with *bla*~CTX-M-9~ and *bla*~CTX-M-15~.

Two AmpC genes CMY-2 and DHA-1 were detected in three and 32 isolates, respectively. All the 35 isolates carrying AmpC genes were also ESBL producers. Additionally, KPC-2 gene was detected in one strain.

Clones Frequently Associated with Hypervirulent *K. pneumoniae* Nationally Disseminated
---------------------------------------------------------------------------------------

Multi-locus sequence typing analysis showed an extensive diversity in 127 ESBL-Kp that 54 STs were identified and no predominant ones existed. The minimum-spanning tree (MST) showed no correlation between STs and geographic distributions (**Figure [1A](#F1){ref-type="fig"}**). Six CCs comprising 45 isolates were identified by eBURST (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**), and the remaining 82 isolates belong to 37 singletons. CC17 (including ST16, ST17, and ST20) was the most prevalent population accounting for 12.6% (16/127), followed by ST86 (*n* = 7), ST107 (*n* = 7), ST873 (*n* = 7), ST37 (*n* = 6), ST776 (*n* = 6), ST23 (*n* = 5), ST290 (*n* = 5). Of note, ST23, ST37, and ST86 account for 14.1% (18/127), and these STs are known frequently associating with hypervirulent *K. pneumoniae* (hvKP) ([@B16]; [@B4]; [@B10]). The major carriers of CTX-M-15 were ST86 (*n* = 7), ST873 (*n* = 6), and ST776 (*n* = 6), and those of CTX-M-14 included ST17 (*n* = 12) and ST107 (*n* = 7).

![**Genetic relationship of ESBL-KP.** **(A)** Minimum-spanning tree (MST) illustrating STs in relation to districts. STs belonging to KpII and KpIII were marked in the red rectangle, and the remaining STs belong to KPI. Thick lines represent single-locus variants, dashed lines correspond to double-locus variants and dotted lines describe three to seven allele differences between the sequence types. **(B)** Phylogenetic tree of 127 ESBL-KP as determined on the basis of the allelic profiles of the seven MLST genes. Branch in blue indicate phylogroup KpI, green indicate KpII (*K. quasipneumoniae*) and red indicate KpIII (*K. variicola*). NC, Northern China; NW, North western China; NE, North eastern China; EC, Eastern China; SC, Southern China; MS, Central southern China; SW, South western China.](fmicb-07-01830-g001){#F1}

ESBL-Producing *K. varricola* and *K. quasipneumoniae* were Identified by Phylogenetic Analysis
-----------------------------------------------------------------------------------------------

Phylogenetic analysis by concatenating sequences of seven MLST loci showed that 54 STs detected in this study were split into three distinct clades, and most STs belong to clade I (**Figure [1B](#F1){ref-type="fig"}**). It is known that *K. pneumoniae* consisted of three phylogenetic groups (KPI, II, and III), and has recently been reclassified as three different species (*K. pneumoniae. K. quasipneumoniae*, and *K. variicola*) ([@B7]; [@B28]; [@B5]). Nine isolates of clade I (ST17, ST290, ST322, ST875, ST896, ST1031, ST1522, and ST1798) and two isolates of clade II (ST138 and ST1031) were consequently sent to WGS for the species determination. Phylogenomic analysis assigned clade I to *K. pneumoniae* (KPI), and clade II to *K. quasipneumoniae* (KPII) (**Figure [1B](#F1){ref-type="fig"}**). The clade III was then supposed to be *K. varricola*. The two *K. quasipneumoniae* isolates carried *bla*~CTX-M-9~ (ST138) and *bla*~CTX-M-14~ (ST1031), respectively, and the one *K. varricola* strain carried *bla*~CTX-M-15~ (ST1181).

The Transmission Mechanism of CTX-M Genes
-----------------------------------------

Plasmids and the genetic environment were analyzed to determine the transmission mechanism of CTX-M genes. The seven CTX-M-14-producing isolates (including *K. pneumoniae* ST17, ST1798, ST896, ST290, ST322, and *K. quasipneumoniae* ST1031) collected from different geographical regions shared a highly homologous plasmid carrying *bla*~CTX-M-14~ gene, of which the backbone was highly similar with pKP1-19 (accession number CP0012884) identified in a *K. pneumoniae* strain isolated in the environment in Australia (**Supplementary Figure [S2A](#SM1){ref-type="supplementary-material"}**). Of note, pKP1-19 did not encode any drug resistance genes. The seven strains shared an identical genetic environment structure as IS*Ecp1-bla*~CTX-M-14~-IS*903* (**Figure [2A](#F2){ref-type="fig"}**).

![**Schematic representation of the *bla*~CTX-M~ environment.** Arrows represent ORFs and their direction of transcription. **(A)** Genetic environment of *bla*~CTX-M-14~ and homologous sequences in plasmid pKP1-9 and pE66An to illustrate the relationship of the three plasmids. **(B)** Genetic environment of *bla*~CTX-M-9~ and homologous sequences in plasmid pKPNDM1 and pMSP071 to illustrate the relationship of the three plasmids. **(C)** Genetic environment of *bla*~CTX-M-3~ and *bla*~CTX-M-15~. pSKLX4211 and pKo6 encoded *bla*~CTX-M-3~ and pSLKX2891, pc15-k and pECN580 were CTX-M-15 carriers. The *bla*~CTX-M-3~ and *bla*~CTX-M-15~ shared an identical genetic environment.](fmicb-07-01830-g002){#F2}

Both CTX-M-9 isolates (including *K. quasipneumoniae* ST138 strain and *K. pneumoniae* ST2316) harbored a similar CTX-M-9 plasmid showing a highly similar backbone with plasmid pFB2.1 carried by *Pluralibacter gergoviae* isolated in Malaysia (accession number CP014776) (**Supplementary Figure [S2B](#SM1){ref-type="supplementary-material"}**). Blasting the contigs harboring *bla*~CTX-M-9~ in GenBank revealed that the best match was pKPNDM1 (accession number JX515588; 99% coverage and 100% identity) carried by a *Raoultella planticola* strain isolated from a patient with post surgical operation infection. This was the only best match showed no less than 99% coverage of the contig. Notably, the *R. planticola* strain was isolated from the northwest of China (Gansu province), where the two *K. pneumoniae* were isolated. An IS*CR1* located upstream of the *bla*~CTX-M-9~ gene (**Figure [2B](#F2){ref-type="fig"}**).

The CTX-M-3 isolate harbored a plasmid carrying the CTX-M-3 gene, of which the backbone was highly similar to a *K. pneumoniae* plasmid pKF3-94 (accession number FJ876826) with CTX-M-15 gene detected from Zhejiang province of China (**Supplementary Figure [S2C](#SM1){ref-type="supplementary-material"}**). Blasting the 7050-bp contig carrying *bla*~CTX-M-3~ gene in GenBank revealed some best matches with 99% coverage and 99% identity, including pHS08204 (accession number KP125893; CTX-M-15 plasmid of *K. pneumoniae* HS08204, from Shanghai), pECN580 (accession number KF914891; CTX-M-15 plasmid of *E. coli*, from Beijing), and pKo6 (accession number KC958437; CTX-M-3 plasmid of *K. pneumoniae*, from Shanghai), pKOX_R1 (accession number CP003684; CTX-M-3 plasmid of *K. oxytoca*, from Taiwan), pc15-k (accession number HQ202266; CTX-M-15 plasmid of *K. pneumoniae*, from Guangzhou), and pKF3-94. These plasmids were detected from different regions of China with different backbones. Examining the genome of the CTX-M-15-producing strain identified a CTX-M-15 plasmid sharing a highly homologous backbone with a *K. pneumoniae* plasmid pc15-k (**Supplementary Figure [S2D](#SM1){ref-type="supplementary-material"}**). Blasting the 10043-bp contig harboring the *bla*~CTX-M-15~ gene revealed the same batch of best matches as those of CTX-M-3-producing plasmids mentioned above (**Figure [2C](#F2){ref-type="fig"}**).

The *bla*~CTX-M-3~ and *bla*~CTX-M-15~ shared an identical genetic environment. A truncated IS*Ecp1* disrupted by IS*1* (at the end of the contig) was found at the upstream of *bla*~CTX-M-3/15~ genes, and genes encoding TEM-1, TnpR of Tn3, and TnpA of Tn3 located downstream of *bla*~CTX-M-3/15~ gene (**Figure [2C](#F2){ref-type="fig"}**).

Discussion
==========

This study illustrated the epidemiological and genetic characteristics of ESBL-Kp causing community-onset infections in 31 secondary hospitals distributed in areas across China. Our results showed that the prevalence rate of community-onset ESBL-Kp (31.8%) was comparable to that of nosocomial-acquired ESBL-Kp revealed by multiple studies across China (30.1--39.7%) ([@B2]; [@B36]). This raises the concern that the dissemination of ESBL-Kp in community has become another challenge for the resistance control in China, which would be even more difficult to be controlled than that in health-care systems.

As the spread pattern of nosocomial-acquired ESBL-Kp, polyclonal dissemination without any predominant clones was identified in this community-onset study. However, the community-onset ESBL-Kp showed a different clonal distribution comparing to that of nosocomial-acquired ESBL-Kp in China. A multi-center study on tertiary hospitals in China showed that ST11 was the most prevalent ST (12.2%) among 74 STs identified in 155 ESBL-Kp ([@B2]), whereas ST17 was the most prevalent one in our study (12.6%). This is concordant with a previous study that ST17 was predominant in CTX-M-14-Kp and CTX-M-15-Kp more likely correlating to community-onset infections ([@B26]). CTX-M-14 and CTX-M-15 were the predominant ESBL genotypes in our community-onset collections, which is the same as that found in the nosocomial studies. However, the population structure of CTX-M-14 and CTX-M-15 producers was different between our collections and the nosocomial-acquired isolates. A multi-center study identified that ST37, 5, 505, 11, and 23 were the major carriers of CTX-M-14, and CTX-M-15 mainly associated with two epidemic clones ST340 and ST15 ([@B2]). In our study, the major carriers of CTX-M-15 were ST86 (*n* = 7), ST873 (*n* = 6), and ST776 (*n* = 6), and the major CTX-M-14 producers consisted of ST17 (*n* = 12) and ST107 (*n* = 7). Neither CTX-M-15 nor CTX-M-14 associate with any known epidemic clones implies that different clones of community-onset ESBL-Kp would become epidemic in the future.

Of note, we found a set of ESBL-producing clones (ST23, ST37, and ST86) known to frequently associate with hvKP. Especially, ST86 was the most abundant clone among CTX-M-15 producers in this study, and is known to correlate to invasive infections such as bacteraemia, pneumonia with septic shock and liver abscess ([@B4]; [@B21]; [@B25]). In this study, five of seven ST86 strains were isolated from sputum of children (aged from 15 days to 3 years) with community-acquired respiratory tract infections, and the other two were isolated from liver abscess and blood in adult patients. To our best knowledge, this is the first report of community dissemination of ST86 in Mainland China. Further study is needed to determine whether the ST86 strains are hvKP and why they emerged in respiratory tract infections in children.

Further investigations revealed various transmission mechanisms employed by different CTX-M genes in the community dissemination. We found that plasmids carried CTX-M-14 identified in seven phylogenetically diverse isolates collected from distinct geographical areas across China shared a similar backbone (**Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}**). This suggests that a batch of plasmids sharing a similar backbone could be an important reservoir for *bla*~CTX-M-14~ in community in China. Interestingly, the segment carrying *bla*~CTX-M-9~ identified in our two isolates got a unique best match (99% coverage and 100% identity) to a part of *R. planticola* plasmid pKPNDM1. Moreover, the *R. planticola* strain was isolated from the same region (Gansu province) with the two isolates. This suggests that *bla*~CTX-M-9~ might not via the horizontal transfer of CTX-M-9-IS*CR1* but that of the whole segment as found in the study spread in that region. Additionally, we found that an identical genetic environment (*Δ*IS*Ecp1-bla*~CTX-M~*-orf477-bla*~TEM-1~-*tnpR-tnpA*) shared by *bla*~CTX-M-15~ and *bla*~CTX-M-3~ identified in two phylogenetically diverse isolates collected from distinct geographical areas. This indicated that both *bla*~CTX-M-15~ and *bla*~CTX-M-3~ might spread mainly via the horizontal transfer of this structure in the community in China.

*K. pneumoniae* was previously classified into three phylogenetic groups (KPI, II, and III), which now are assigned to three different species (*K. pneumoniae. K. quasipneumoniae*, and *K. variicola*), respectively. *K. quasipneumoniae* (KPII) and *K. variicola* (KPIII) were previously thought to be more susceptible than *K. pneumoniae* (KpI) isolates to antimicrobial agents, and less frequently cause infections ([@B6]; [@B11]; [@B15]). *K. variicola* is an environmental bacterium mainly associated with plants. Rare reports are available of infections caused by *K. quasipneumoniae* and *K. variicola* ([@B15]). [@B23] found that *K. variicola* infections correlate to higher mortality comparing to *K. pneumoniae* infections. Few studies showed the ESBL-producing KPII and KPIII strains can cause nosocomial infections ([@B32]; [@B23]; [@B15]). The present study revealed the emergency of ESBL-producing *K. quasipneumoniae* and *K. variicola* causing community-onset infections. The lack of accurate identification methods for the three species may underestimate the severity of *K. quasipneumoniae* and *K. variicola* infections. Surveillance of ESBL-producing *K. quasipneumoniae* and *K. variicola* would be helpful to prevent the further prevalence.

In summary, this study highlights the challenge of ESBL dissemination in community in China. Various transmission mechanisms are responsible for the spread of the most common CTX-M genes in community. The prevalence of STs frequently associating with hvKP should be of concern. Surveillance of ESBL-KP causing community-onset infections now appears imperative.

Author Contributions
====================

Conceived and designed the experiments: JZ, YX, KZ, LZ, BZ, LL, and JZ. Performed the experiments: JZ, JJ, ZW, PS, and LZ. Analyzed the data: JZ, KZ, and YX. Wrote the paper: JZ and KZ.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work was supported by the National Basic Research Program of China (973 program, No. 2015CB554201), National Natural Science Foundation of China (Grant No. 81361138021 and 81301461).

We thank the following directors of seven geographical regions in this study for technical support and quality control: Xingyu Ni, Ziyong Sun, Zhidong Hu, Yunzhuo Chu, Ping Ji, Tiantuo Zhang, and Hua Yu. We also thank the supervisors of 31 county hospitals for strain collection, preservation, and transport. We thank the team of curators of the Institute Pasteur MLST and whole genome MLST databases for curating the data and making them publicly available at <http://bigsdb.web.pasteur.fr/>.

<http://www.lahey.org/Studies/>

<http://bigsdb.web.pasteur.fr/>

Supplementary Material
======================

The Supplementary Material for this article can be found online at: <http://journal.frontiersin.org/article/10.3389/fmicb.2016.01830/full#supplementary-material>

###### 

Click here for additional data file.

[^1]: Edited by: *Octavio Luiz Franco, Universidade Católica de Brasília, Brazil*

[^2]: Reviewed by: *Jian-Hua Liu, South China Agricultural University, China; Alex Leite Pereira, University of Brasília, Brazil*

[^3]: ^†^*Deceased*

[^4]: ^‡^*These authors have contributed equally to this work.*

[^5]: This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology
